Khadidja Abdallah
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Navigating market access after conditional reimbursement: a communication roadmap for disinvesting orphan drugs.
Journal: International journal of technology assessment in health care
Published: January 16, 2026
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: October 16, 2024
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease.
Journal: Clinical drug investigation
Published: July 22, 2024
Nothing about us without us: Advocacy and engagement in genetic medicine.
Journal: Science translational medicine
Published: May 08, 2024
How to balance valuable innovation with affordable access to medicines in Belgium?
Journal: Frontiers in pharmacology
Published: June 03, 2022
Exploring alternative financing models and early access schemes for orphan drugs: a Belgian case study.
Journal: Orphanet journal of rare diseases
Published: March 15, 2022
A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe.
Journal: Frontiers in pharmacology
Published: July 24, 2021
Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review.
Journal: Frontiers in pharmacology
Published: November 18, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026